Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 08, 2021

SELL
$222.0 - $252.62 $684,648 - $779,080
-3,084 Closed
0 $0
Q3 2020

Nov 05, 2020

BUY
$175.56 - $226.45 $541,427 - $698,371
3,084 New
3,084 $698,000
Q4 2019

Jan 27, 2020

SELL
$126.05 - $152.76 $478,233 - $579,571
-3,794 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$125.07 - $143.67 $474,515 - $545,083
3,794 New
3,794 $502,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.32B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Hgk Asset Management Inc Portfolio

Follow Hgk Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hgk Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hgk Asset Management Inc with notifications on news.